Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis

Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting

Sep 15, 2014, 16:30 ET from Amgen

$countyNameToPathMap.put("sp